Advanced in Muscle Invasive Bladder Cancer

Dr. Andrea B. Apolo

Internal Medicine

10 Center Dr Rm 12n226,

Bethesda, MD

Clinical Trials:Currently Recruiting for 1 Trial

Advanced in Muscle Invasive Bladder Cancer

10 Center Dr Rm 12n226,

Bethesda, MD

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrea Apolo is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Apolo is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Penile Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and Neuroendocrine Tumor.

Her clinical research consists of co-authoring 132 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Muscle Invasive Bladder Cancer.

Specialties

Internal Medicine

Licenses

Internal Medicine in NY

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Locations

10 Center Dr Rm 12n226, Bethesda, MD 20892

Call: 301-451-6050

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Study of Olaparib (AZD2281) in Patients With Metastatic/Advanced Urothelial Carcinoma and Other Genitourinary Tumors With DNA-Repair Defects

Enrollment Status: Recruiting

Publish Date: September 03, 2025

Intervention Type: Procedure, Drug

Study Drug: Olaparib

Study Phase: Phase 2

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation

Enrollment Status: Active_not_recruiting

Publish Date: October 09, 2025

Intervention Type: Other, Biological, Procedure

Study Drug: Pembrolizumab

Study Phase: Phase 3

A Phase 1 Study of Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination With Ipilimumab (CaboNivoIpi) in Patients With Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Enrollment Status: Active_not_recruiting

Publish Date: September 08, 2025

Intervention Type: Procedure, Biological, Drug

Study Drugs: Cabozantinib S-malate, Ipilimumab, Nivolumab

Study Phase: Phase 1

View 2 Less Clinical Trial

132 Total Publications

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 11, 2025

View All 132 Publications

Similar Doctors

Advanced in Muscle Invasive Bladder Cancer

Dr. Christopher P. Mcmanus

Internal Medicine

Advanced in Muscle Invasive Bladder Cancer

Dr. Christopher P. Mcmanus

Internal Medicine

Privia Medical Group, LLC

2525 10th St N, Cp And Rp Mcmanus Md,

Arlington, VA

(6.7 miles away)

703-525-7040

Languages Spoken:

English, Spanish

See accepted insurances

Accepting New Patients

Offers Telehealth

Christopher Mcmanus is a primary care provider, practicing in Internal Medicine in Arlington, Virginia. Dr. Mcmanus is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Type 1 Diabetes (T1D), and Hypertension. Dr. Mcmanus is currently accepting new patients.

Advanced in Muscle Invasive Bladder Cancer

Dr. Robert C. Clark

Internal Medicine

Advanced in Muscle Invasive Bladder Cancer

Dr. Robert C. Clark

Internal Medicine

Medstar Medical Group Ii LLC

6410 Rockledge Dr, Suite 401,

Bethesda, MD

(3.5 miles away)

301-897-5001

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Offers Telehealth

Robert Clark is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Clark is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Chronic B-Cell Leukemia (CBCL), Colonoscopy, and Endoscopy. Dr. Clark is currently accepting new patients.

Advanced in Muscle Invasive Bladder Cancer

Dr. Madina Haque

Internal Medicine

Advanced in Muscle Invasive Bladder Cancer

Dr. Madina Haque

Internal Medicine

Virginia Hospital Center Physician Group LLC

1635 N George Mason Dr, Suite 190,

Arlington, VA

(6.5 miles away)

703-558-6077

Languages Spoken:

English, Bengali, Hindi, Spanish

See accepted insurances

Accepting New Patients

Offers Telehealth

Madina Haque is a primary care provider, practicing in Internal Medicine in Arlington, Virginia. Dr. Haque is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Hepatitis, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Diabetic Hyperglycemic Hyperosmolar Syndrome. Dr. Haque is currently accepting new patients.

VIEW MORE MUSCLE INVASIVE BLADDER CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Apolo's expertise for a condition

ConditionClose